Unknown

Dataset Information

0

IL-27 Counteracts Neuropathic Pain Development Through Induction of IL-10.


ABSTRACT: Neuroimmune-glia interactions have been implicated in the development of neuropathic pain. Interleukin-27 (IL-27) is a cytokine that presents regulatory activity in inflammatory conditions of the central nervous system. Thus, we hypothesized that IL-27 would participate in the neuropathic pain process. Here, we found that neuropathic pain caused by peripheral nerve injury (spared nerve injury model; SNI), was enhanced in IL-27-deficient(-/-) mice, whereas nociceptive pain is similar to that of wild-type mice. SNI induced an increase in the expression of IL-27 and its receptor subunit (Wsx1) in the sensory ganglia and spinal cord. IL-27 receptor was expressed mainly in resident macrophage, microglia, and astrocytes of the sensory ganglia and spinal cord, respectively. Finally, we identify that the antinociceptive effect of IL-27 was not observed in IL-10-/- mice. These results provided evidence that IL-27 is a cytokine produced after peripheral nerve injury that counteracts neuropathic pain development through induction of the antinociceptive cytokine IL-10. In summary, our study unraveled the role of IL-27 as a regulatory cytokine that counteracts the development of neuropathic pain after peripheral nerve damage. In conclusion, they indicate that immunotherapies based on IL-27 could emerge as possible therapeutic approaches for the prevention of neuropathic pain development after peripheral nerve injury.

SUBMITTER: Fonseca MM 

PROVIDER: S-EPMC6997342 | BioStudies | 2019-01-01

REPOSITORIES: biostudies

Similar Datasets

2006-01-01 | S-EPMC1851944 | BioStudies
2014-09-29 | E-GEOD-60033 | ArrayExpress
2009-01-01 | S-EPMC2813708 | BioStudies
2009-01-01 | S-EPMC2768229 | BioStudies
2020-01-01 | S-EPMC6916715 | BioStudies
| GSE60033 | GEO
2007-01-01 | S-EPMC3224847 | BioStudies
2020-01-01 | S-EPMC7409160 | BioStudies
2016-01-01 | S-EPMC5068091 | BioStudies
2005-01-01 | S-EPMC6725885 | BioStudies